Features of multiple endocrine neoplasia type 1 and 2A in a patient with both RET and MEN1 germline mutations

Spandana J. Brown; Daniel L. Riconda; Feibi Zheng; Gilchrist L. Jackson; Liye Suo; Richard J. Robbins

doi:10.1210/JENDSO/BVAA020

Features of multiple endocrine neoplasia type 1 and 2A in a patient with both RET and MEN1 germline mutations

Spandana J. Brown, Daniel L. Riconda, Feibi Zheng, Gilchrist L. Jackson, Liye Suo, Richard J. Robbins

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The coexistence of multiple endocrine neoplasia type 1 (MEN1) and type 2A (MEN2A) is a rare occurrence and has been reported only twice in the literature. We present a patient with primary hyperparathyroidism and medullary thyroid cancer with strong family history of both MEN1- A nd MEN2A-associated conditions. Genetic testing showed the patient had a novel MEN1 loss-of-function mutation, c0.525_526insTT (p.Ala176Leufs*10), and an uncommon Cys630Tyr RET mutation. This case highlights the importance of obtaining a detailed family history when heritable endocrine disorders are suspected.

Original language	English (US)
Pages (from-to)	1-6
Number of pages	6
Journal	Journal of the Endocrine Society
Volume	4
Issue number	4
DOIs	https://doi.org/10.1210/JENDSO/BVAA020
State	Published - 2020

Keywords

Hyperparathyroidism
MEN1
MEN1
MEN2A
Medullary thyroid cancer
RET

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism

Access to Document

10.1210/JENDSO/BVAA020

Cite this

@article{03337ac6dc2f4018b7f639a8ade522e0,

title = "Features of multiple endocrine neoplasia type 1 and 2A in a patient with both RET and MEN1 germline mutations",

abstract = "The coexistence of multiple endocrine neoplasia type 1 (MEN1) and type 2A (MEN2A) is a rare occurrence and has been reported only twice in the literature. We present a patient with primary hyperparathyroidism and medullary thyroid cancer with strong family history of both MEN1- A nd MEN2A-associated conditions. Genetic testing showed the patient had a novel MEN1 loss-of-function mutation, c0.525_526insTT (p.Ala176Leufs*10), and an uncommon Cys630Tyr RET mutation. This case highlights the importance of obtaining a detailed family history when heritable endocrine disorders are suspected.",

keywords = "Hyperparathyroidism, MEN1, MEN1, MEN2A, Medullary thyroid cancer, RET",

author = "Brown, {Spandana J.} and Riconda, {Daniel L.} and Feibi Zheng and Jackson, {Gilchrist L.} and Liye Suo and Robbins, {Richard J.}",

note = "Publisher Copyright: {\textcopyright} 2020 Endocrine Society.",

year = "2020",

doi = "10.1210/JENDSO/BVAA020",

language = "English (US)",

volume = "4",

pages = "1--6",

journal = "Journal of the Endocrine Society",

issn = "2472-1972",

publisher = "Endocrine Society",

number = "4",

}

TY - JOUR

T1 - Features of multiple endocrine neoplasia type 1 and 2A in a patient with both RET and MEN1 germline mutations

AU - Brown, Spandana J.

AU - Riconda, Daniel L.

AU - Zheng, Feibi

AU - Jackson, Gilchrist L.

AU - Suo, Liye

AU - Robbins, Richard J.

PY - 2020

Y1 - 2020

N2 - The coexistence of multiple endocrine neoplasia type 1 (MEN1) and type 2A (MEN2A) is a rare occurrence and has been reported only twice in the literature. We present a patient with primary hyperparathyroidism and medullary thyroid cancer with strong family history of both MEN1- A nd MEN2A-associated conditions. Genetic testing showed the patient had a novel MEN1 loss-of-function mutation, c0.525_526insTT (p.Ala176Leufs*10), and an uncommon Cys630Tyr RET mutation. This case highlights the importance of obtaining a detailed family history when heritable endocrine disorders are suspected.

AB - The coexistence of multiple endocrine neoplasia type 1 (MEN1) and type 2A (MEN2A) is a rare occurrence and has been reported only twice in the literature. We present a patient with primary hyperparathyroidism and medullary thyroid cancer with strong family history of both MEN1- A nd MEN2A-associated conditions. Genetic testing showed the patient had a novel MEN1 loss-of-function mutation, c0.525_526insTT (p.Ala176Leufs*10), and an uncommon Cys630Tyr RET mutation. This case highlights the importance of obtaining a detailed family history when heritable endocrine disorders are suspected.

KW - Hyperparathyroidism

KW - MEN1

KW - MEN2A

KW - Medullary thyroid cancer

KW - RET

UR - http://www.scopus.com/inward/record.url?scp=85101345684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101345684&partnerID=8YFLogxK

U2 - 10.1210/JENDSO/BVAA020

DO - 10.1210/JENDSO/BVAA020

M3 - Article

C2 - 32190804

AN - SCOPUS:85101345684

SN - 2472-1972

VL - 4

SP - 1

EP - 6

JO - Journal of the Endocrine Society

JF - Journal of the Endocrine Society

IS - 4

ER -

Features of multiple endocrine neoplasia type 1 and 2A in a patient with both RET and MEN1 germline mutations

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this